Placebo News and Research RSS Feed - Placebo News and Research

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of research findings today in the journal Science Translational Medicine. [More]
Preventing C. difficile infections could save thousands of lives and millions of health care dollars

Preventing C. difficile infections could save thousands of lives and millions of health care dollars

The constant fear of having an embarrassing bathroom accident paralyzed Judy Post. Mental, physical and emotional stress consumed her. She wondered if her life would ever return to normal. [More]
Brazilian researchers propose new way for treating thalassemia major

Brazilian researchers propose new way for treating thalassemia major

Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia. [More]
Researchers to study effect of watermelon juice in reducing heart disease

Researchers to study effect of watermelon juice in reducing heart disease

University of Alabama researchers soon will launch a study that looks at watermelon juice as a way to reduce heart disease. [More]
Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

The inability to hear subtle changes in pitch, a common and debilitating problem for people with schizophrenia, is due to dysfunctional N-methyl-D-aspartate (NMDA) brain receptors, according to a study by Columbia University Medical Center researchers. [More]
New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease. [More]
Alpha blockers benefit patients with larger kidney stones

Alpha blockers benefit patients with larger kidney stones

Nearly one in 11 Americans will have a kidney stone in their lifetime, causing pain, sometimes missed work and, often, a lot of money. [More]
Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin -- the active compound in hallucinogenic "magic mushrooms." [More]
Drexel researchers one step closer to offering new treatment for chronic wounds

Drexel researchers one step closer to offering new treatment for chronic wounds

Drexel University researchers are one step closer to offering a new treatment for the millions of patients who suffer from slow-healing, chronic wounds. [More]
Study shows heart medications prevent cardiovascular damage during breast cancer treatment

Study shows heart medications prevent cardiovascular damage during breast cancer treatment

Heart medication taken in combination with chemotherapy reduces the risk of serious cardiovascular damage in patients with early-stage breast cancer, according to results from a new landmark clinical trial. [More]
NIH-supported first HIV vaccine efficacy study begins in South Africa

NIH-supported first HIV vaccine efficacy study begins in South Africa

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. [More]
Pharmacotherapy combined with rehabilitation program offers hope for traumatic brain injury patients

Pharmacotherapy combined with rehabilitation program offers hope for traumatic brain injury patients

Pharmacological therapy combined with a rehabilitation program that teaches how to compensate for memory and attention problems offers new hope for people who suffer the consequences of traumatic brain injury. [More]
Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

It is not only overseas holidays that can be ruined by the dreaded Traveller's Diarrhoea. [More]
Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide. [More]
New combinatination therapy shows promise in treating patients with traumatic brain injury

New combinatination therapy shows promise in treating patients with traumatic brain injury

A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported. [More]
Vitamin D supplementation improves autism symptoms, study shows

Vitamin D supplementation improves autism symptoms, study shows

Vitamin D supplementation improved symptoms of autism in a recent trial. [More]
Results of high-impact clinical trials could improve kidney-related medical care

Results of high-impact clinical trials could improve kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2016, November 15-20 at McCormick Place in Chicago, IL. [More]
Walnuts could be key to happier state-of-mind in young healthy men

Walnuts could be key to happier state-of-mind in young healthy men

College can be a stressful time for young adults as they figure out how to manage intense daily routines that include work, study and play. [More]
Dietary sodium restriction may provide kidney and heart benefits for CKD patients

Dietary sodium restriction may provide kidney and heart benefits for CKD patients

New research indicates that reducing sodium intake may provide kidney and heart benefits for patients with chronic kidney disease (CKD). [More]
Arthritis drug induces response and remission in patients with Crohn's disease, study finds

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn's disease. [More]
Advertisement
Advertisement